Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
February-2020 Volume 19 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2020 Volume 19 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Changes of cardiac troponin I and hypersensitive C‑reactive protein prior to and after treatment for evaluating the early therapeutic efficacy of acute myocardial infarction treatment

  • Authors:
    • Li Wang
    • Bing Liao
    • Jian Yu
    • Ling Chen
    • Xiaozhong Cai
    • Li Liu
    • Kaiwen Hou
    • Minghao Zhang
  • View Affiliations / Copyright

    Affiliations: Lab Teaching and Management Center, Chongqing Medical University, Chongqing 400016, P.R. China, Department of Laboratory Medicine, The Ninth People's Hospital of Chongqing, Chongqing 400700, P.R. China, Outpatient Department, The General Hospital of Western Theater Command, Chengdu, Sichuan 610083, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1121-1128
    |
    Published online on: December 6, 2019
       https://doi.org/10.3892/etm.2019.8206
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to evaluate the utility of the extent of change (C) and change rate (Cr) of cardiac troponin I (cTnI) and hypersensitive C‑reactive protein (hs‑CRP) prior to and after treatment in evaluating the early therapeutic efficacy of acute myocardial infarction (AMI) treatment. A total of 145 patients with AMI who received regular MI treatment were enrolled in the present study. Patients were divided into the effective group and the ineffective group based on the early therapeutic efficacy. The values of two parameters, namely the serum levels of cTnI and hs‑CRP, were collected prior to and after AMI treatment. Data were analyzed by using the t‑test, Chi‑squared test, logistic regression and receiver operating characteristic (ROC) curve analysis. Compared with those in the ineffective group, the values of cTnI and hs‑CRP after treatment [cTnI(post) and hs‑CRP(post)], as well as their C and Cr values, were significantly decreased in the effective group (P<0.01). Furthermore, the positive rates (PR) of cTnI(post), hs‑CRP(post), (cTnI+hs‑CRP)(post), C(cTnI), C(hs‑CRP) and C(cTnI+hs‑CRP) were significantly lower in the effective group compared with those in the ineffective group (P<0.01). It was indicated that hs‑CRP(post) and C(hs‑CRP), as well as the PR‑cTnI(post) and the PR‑C(cTnI), may be used as independent factors for early therapeutic efficacy evaluation (P<0.05). In addition, the area under the ROC curve, as well as the associated sensitivity and specificity analysis for cTnI(post), hs‑CRP(post), C(cTnI or hs‑CRP) and Cr(cTnI or hs‑CRP), all indicated that these parameters were able to distinguish between the effective and the ineffective groups. The present study revealed that compared with the cTnI(post) and hs‑CRP(post), the C and the Cr of cTnI and hs‑CRP may have enhanced value for evaluating the early therapeutic efficacy of AMI treatment.
View Figures

Figure 1

Figure 2

View References

1 

Reed GW, Rossi JE and Cannon CP: Acute myocardial infarction. Lancet. 389:197–210. 2017. View Article : Google Scholar : PubMed/NCBI

2 

Yu J, Wang L, Peng Y, Xiong M, Cai X, Luo J and Zhang M: Dynamic monitoring of erythrocyte distribution width (RDW) and Platelet Distribution Width (PDW) in treatment of acute myocardial infarction. Med Sci Monit. 23:5899–5906. 2017. View Article : Google Scholar : PubMed/NCBI

3 

Raskovalova T, Twerenbold R, Collinson PO, Keller T, Bouvaist H, Folli C, Giavarina D, Lotze U, Eggers KM, Dupuy AM, et al: Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: A systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care. 3:18–27. 2014. View Article : Google Scholar : PubMed/NCBI

4 

Ramesh G, Sai NVB, Gururaj P, Bhupal R and Patel N: Association of metabolic syndrome and level of hs-CRP, Lp(a), and serum ferritin in young Asian patients (≤45 years) with acute myocardial infarction. Interv Med Appl Sci. 10:65–69. 2018.PubMed/NCBI

5 

Yoshinaga R, Doi Y, Ayukawa K and Ishikawa S: High-sensitivity C reactive protein as a predictor of inhospital mortality in patients with cardiovascular disease at an emergency department: A retrospective cohort study. BMJ Open. 7:e0151122017. View Article : Google Scholar : PubMed/NCBI

6 

Li J, Wang L, Wang Q, Xin Z, Liu Y and Zhao Q: Diagnostic value of carotid artery ultrasound and hypersensitive C-reactive protein in Type 2 diabetes mellitus patients with acute myocardial infarction in Chinese population. Medicine (Baltimore). 97:e123342018. View Article : Google Scholar : PubMed/NCBI

7 

Yip HK, Wu CJ, Chang HW, Yang CH, Yeh KH, Chua S and Fu M: Levels and values of serum high-sensitivity C-reactive protein within 6 hours after the onset of acute myocardial infarction. Chest. 126:1417–1422. 2004. View Article : Google Scholar : PubMed/NCBI

8 

Koskinas KC, Zaugg S, Yamaji K, García-García HM, Taniwaki M, Klingenberg R, Moschovitis A, Lüscher TF, van Tits LJ, Matter CM, et al: Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy. Atherosclerosis. 247:154–160. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, et al: ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary. A report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. 42:1493–1531. 2003. View Article : Google Scholar : PubMed/NCBI

10 

Gao RL: Guidelines for the diagnosis and treatment of acute myocardial infarction. Chin J Cardiol. 29:710–725. 2001.

11 

Swirski FK and Nahrendorf M: Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science. 339:161–166. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Mackman N: Triggers, targets and treatments for thrombosis. Nature. 451:914–918. 2008. View Article : Google Scholar : PubMed/NCBI

13 

Baars T, Neumann U, Jinawy M, Hendricks S, Sowa JP, Kälsch J, Riemenschneider M, Gerken G, Erbel R, Heider D and Canbay A: In acute myocardial infarction liver parameters are associated with stenosis diameter. Medicine (Baltimore). 95:e28072016. View Article : Google Scholar : PubMed/NCBI

14 

Sun T, Zhang L, Li X, Chen F, Li Y, Ma X and Yu F: MicroRNA-1 and circulating microvesicles mediate the protective effects of dantonic in acute myocardial infarction rat models. Front Physiol. 9:6642018. View Article : Google Scholar : PubMed/NCBI

15 

Elsman P, Zijlstra F, Miedema K, Hoorntje JC, Dikkeschei LD, Slingerland RJ, Reiffers S, de Boer MJ and Suryapranata H: The predictive value of cumulative lactate dehydrogenase release within the first 72 h of acute myocardial infarction in patients treated with primary angioplasty. Ann Clin Biochem. 41:142–148. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Young I and Rifai N: High-sensitivity C-reactive protein and cardiovascular disease. Clin Chem. 55:201–202. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Cichota LC, Moresco RN, Duarte MM and da Silva JE: Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease. J Clin Lab Anal. 22:1–5. 2008. View Article : Google Scholar : PubMed/NCBI

18 

Ridker PM, Cushman M, Stampfer MJ, Tracy RP and Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 336:973–979. 1997. View Article : Google Scholar : PubMed/NCBI

19 

Dibra A, Mehilli J, Schwaiger M, Schühlen H, Bollwein H, Braun S, Neverve J, Schömig A and Kastrati A: Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment. Eur Heart J. 24:1128–1133. 2003. View Article : Google Scholar : PubMed/NCBI

20 

Suleiman M, Khatib R, Agmon Y, Mahamid R, Boulos M, Kapeliovich M, Levy Y, Beyar R, Markiewicz W, Hammerman H and Aronson D: Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol. 47:962–968. 2006. View Article : Google Scholar : PubMed/NCBI

21 

Stumpf C, Sheriff A, Zimmermann S, Schaefauer L, Schlundt C, Raaz D, Garlichs CD and Achenbach S: C-reactive protein levels predict systolic heart failure and outcome in patients with first ST-elevation myocardial infarction treated with coronary angioplasty. Arch Med Sci. 13:1086–1093. 2017. View Article : Google Scholar : PubMed/NCBI

22 

Zhang XG, Wang NS and Gao XP: Risk factors for cardiovascular disease in patients with chronic kidney disease. J Clin Kidney Dis. 10:220–222. 2010.

23 

Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Rubini Gimenez M, Badertscher P and Mueller C: Clinical use of high-sensitivity cardiac troponin in patients with suspected myocardial infarction. J Am Coll Cardiol. 70:996–1012. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Xu GX, Wang F and Yang YQ: Clinical significance of detection of plasma LP (a) Hcy hs-CRP and cTnI levels in patients with acute myocardial infarction. Int J Laboratory Med. 2466–2468. 2014.

25 

Muhlestein JB, Lappe DL, Anderson JL, Muhlestein JB, Budge D, May HT, Bennett ST, Bair TL and Horne BD: Both initial red cell distribution width (RDW) and change in RDW during heart failure hospitalization are associated with length of hospital stay and 30-day outcomes. Int J Lab Hematol. 38:328–337. 2016. View Article : Google Scholar : PubMed/NCBI

26 

Fan J, Ma J, Xia N, Sun L, Li B and Liu H: Clinical value of combined detection of CK-MB, MYO, cTnI and plasma NT-proBNP in diagnosis of acute myocardial infarction. Clin Lab. 63:427–433. 2017. View Article : Google Scholar : PubMed/NCBI

27 

Jia CY, Wang L, Mao ZG, Zhang JL and Zhang L: Combined myocardial injury markers for diagnosis of acute myocardial infarction. Sichuan Da Xue Xue Bao Yi Xue Ban. 40:1082–1085. 2009.(In Chinese). PubMed/NCBI

28 

Vogiatzis I, Dapcevic I, Datsios A, Koutsambasopoulos K, Gontopoulos A and Grigoriadis S: A comparison of prognostic value of the levels of ProBNP and troponin T in patients with Acute Coronary Syndrome (ACS). Med Arch. 70:269–273. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Aseri ZA, Habib SS, Alhomida AS and Khan HA: Relationship of high sensitivity C-reactive protein with cardiac biomarkers in patients presenting with acute coronary syndrome. J Coll Physicians Surg Pak. 24:387–391. 2014.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang L, Liao B, Yu J, Chen L, Cai X, Liu L, Hou K and Zhang M: Changes of cardiac troponin I and hypersensitive C‑reactive protein prior to and after treatment for evaluating the early therapeutic efficacy of acute myocardial infarction treatment. Exp Ther Med 19: 1121-1128, 2020.
APA
Wang, L., Liao, B., Yu, J., Chen, L., Cai, X., Liu, L. ... Zhang, M. (2020). Changes of cardiac troponin I and hypersensitive C‑reactive protein prior to and after treatment for evaluating the early therapeutic efficacy of acute myocardial infarction treatment. Experimental and Therapeutic Medicine, 19, 1121-1128. https://doi.org/10.3892/etm.2019.8206
MLA
Wang, L., Liao, B., Yu, J., Chen, L., Cai, X., Liu, L., Hou, K., Zhang, M."Changes of cardiac troponin I and hypersensitive C‑reactive protein prior to and after treatment for evaluating the early therapeutic efficacy of acute myocardial infarction treatment". Experimental and Therapeutic Medicine 19.2 (2020): 1121-1128.
Chicago
Wang, L., Liao, B., Yu, J., Chen, L., Cai, X., Liu, L., Hou, K., Zhang, M."Changes of cardiac troponin I and hypersensitive C‑reactive protein prior to and after treatment for evaluating the early therapeutic efficacy of acute myocardial infarction treatment". Experimental and Therapeutic Medicine 19, no. 2 (2020): 1121-1128. https://doi.org/10.3892/etm.2019.8206
Copy and paste a formatted citation
x
Spandidos Publications style
Wang L, Liao B, Yu J, Chen L, Cai X, Liu L, Hou K and Zhang M: Changes of cardiac troponin I and hypersensitive C‑reactive protein prior to and after treatment for evaluating the early therapeutic efficacy of acute myocardial infarction treatment. Exp Ther Med 19: 1121-1128, 2020.
APA
Wang, L., Liao, B., Yu, J., Chen, L., Cai, X., Liu, L. ... Zhang, M. (2020). Changes of cardiac troponin I and hypersensitive C‑reactive protein prior to and after treatment for evaluating the early therapeutic efficacy of acute myocardial infarction treatment. Experimental and Therapeutic Medicine, 19, 1121-1128. https://doi.org/10.3892/etm.2019.8206
MLA
Wang, L., Liao, B., Yu, J., Chen, L., Cai, X., Liu, L., Hou, K., Zhang, M."Changes of cardiac troponin I and hypersensitive C‑reactive protein prior to and after treatment for evaluating the early therapeutic efficacy of acute myocardial infarction treatment". Experimental and Therapeutic Medicine 19.2 (2020): 1121-1128.
Chicago
Wang, L., Liao, B., Yu, J., Chen, L., Cai, X., Liu, L., Hou, K., Zhang, M."Changes of cardiac troponin I and hypersensitive C‑reactive protein prior to and after treatment for evaluating the early therapeutic efficacy of acute myocardial infarction treatment". Experimental and Therapeutic Medicine 19, no. 2 (2020): 1121-1128. https://doi.org/10.3892/etm.2019.8206
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team